methyl (E) 6-(1,3-dihydro-7-methyl-3-oxo-4-p-toluenesulfonyloxy-6-vinylisobenzofuran-5-yl)-4-methyl-4-hexenoate | 171489-85-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl (E) 6-(1,3-dihydro-7-methyl-3-oxo-4-p-toluenesulfonyloxy-6-vinylisobenzofuran-5-yl)-4-methyl-4-hexenoate
• 英文别名: methyl (E)-6-[6-ethenyl-7-methyl-4-(4-methylphenyl)sulfonyloxy-3-oxo-1H-2-benzofuran-5-yl]-4-methylhex-4-enoate
• CAS: 171489-85-3
• 化学式: C₂₆H₂₈O₇S
• 分子量: 484.57
• InChiKey: UIIPRTCWRWXLCL-RQZCQDPDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  34
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  104
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  methyl (E) 6-(1,3-dihydro-7-methyl-3-oxo-4-p-toluenesulfonyloxy-6-vinylisobenzofuran-5-yl)-4-methyl-4-hexenoate 在 mer-RhCl3(PPh3)3 EtOAc MTBE 作用下， 以 苯 、 乙醇 为溶剂， 反应 11.0h， 以to afford methyl (E) 6-(1,3-dihydro-6-ethyl-7-methyl-3-oxo-4-p-toluenesulfonyloxyisobenzofuran-5-yl)-4-methyl-4-hexenoate, mp 101.3°-102.08° C.的产率得到methyl (E) 6-(1,3-dihydro-6-ethyl-7-methyl-3-oxo-4-p-toluenesulfonyloxyisobenzofuran-5-yl)-4-methyl-4-hexenoate
  参考文献：
  名称：

  6-substituted mycophenolic acid and derivatives

  摘要：

  揭示的6-取代衍生物是治疗剂，对于使用麦考酚酸和/或麦考酚酯莫费特治疗的疾病状态具有优势。

  公开号：

  US05536747A1
• 作为产物：
  描述：

  霉酚酸 在 吡啶 、 N-甲基吡咯烷酮 、 2,3,5-三甲基吡啶 、 4-二甲氨基吡啶 、 tris(dibenzylideneacetone)dipalladium(0) chloroform complex 、 三苯胂 、 对甲苯磺酸 、 三乙胺 、 lithium chloride 、 lithium iodide 作用下， 以 二氯甲烷 为溶剂， 反应 57.75h， 生成 methyl (E) 6-(1,3-dihydro-7-methyl-3-oxo-4-p-toluenesulfonyloxy-6-vinylisobenzofuran-5-yl)-4-methyl-4-hexenoate
  参考文献：
  名称：

  Structure−Activity Relationships for Inhibition of Inosine Monophosphate Dehydrogenase by Nuclear Variants of Mycophenolic Acid

  摘要：

  Structure-activity relationships in the region of the phthalide ring of the inosine monophosphate dehydrogenase inhibitor mycophenolic acid have been explored. Replacement of the lactone ring with other cyclic moieties resulted in loss of potency, especially for larger groups. Replacement of the ring by acyclic substituents also indicated a strong sensitivity to steric bulk. A phenolic hydroxyl group, with an adjacent hydrogen bond acceptor, was found to be essential for high potency. The aromatic methyl group was essential for activity; the methoxyl group could be replaced by ethyl to give a compound with 2-4 times the potency of mycophenolic acid in vitro and in vivo.

  DOI：

  10.1021/jm9603633

文献信息

• Method of using 4-amino 6-substituted mycophenolic acid and derivatives
  申请人：Syntex (U.S.A.) Inc.

  公开号：US05525602A1

  公开（公告）日：1996-06-11

  The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil and other immunosuppressant agents.

  所披露的霉酚酸衍生物是治疗疾病状态中的治疗剂，适用于霉酚酸和/或麻酮酯酸酯以及其他免疫抑制剂。
• 4-amino 6-substitutes mycophenolic acid and derivatives
  申请人：——

  公开号：US05554612A1

  公开（公告）日：1996-09-10

  The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil and other immunosuppressant agents.

  披露的甲氧苯酸衍生物是治疗用药，在治疗需要甲氧苯酸和/或甲氧苯酸酯酰基等免疫抑制剂的疾病状态中具有优势。
• Structure−Activity Relationships for Inhibition of Inosine Monophosphate Dehydrogenase by Nuclear Variants of Mycophenolic Acid
  作者：Peter H. Nelson、Stephen F. Carr、Bruce H. Devens、Elsie M. Eugui、Fidencio Franco、Carlos Gonzalez、Ronald C. Hawley、David G. Loughhead、David J. Milan、Eva Papp、John W. Patterson、Sussan Rouhafza、Eric B. Sjogren、David B. Smith、Rebecca A. Stephenson、Francisco X. Talamas、Ann-Marie Waltos、Robert J. Weikert、John C. Wu

  DOI：10.1021/jm9603633

  日期：1996.1.1

  Structure-activity relationships in the region of the phthalide ring of the inosine monophosphate dehydrogenase inhibitor mycophenolic acid have been explored. Replacement of the lactone ring with other cyclic moieties resulted in loss of potency, especially for larger groups. Replacement of the ring by acyclic substituents also indicated a strong sensitivity to steric bulk. A phenolic hydroxyl group, with an adjacent hydrogen bond acceptor, was found to be essential for high potency. The aromatic methyl group was essential for activity; the methoxyl group could be replaced by ethyl to give a compound with 2-4 times the potency of mycophenolic acid in vitro and in vivo.
• 6-substituted mycophenolic acid and derivatives
  申请人：Syntex (U.S.A.) Inc.

  公开号：US05444072A1

  公开（公告）日：1995-08-22

  The disclosed 6-substituted derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil.

  所披露的6-取代衍生物是治疗剂，在治疗适用于麦考酚酸和/或麦考酚酯酶的疾病状态中具有优势。